NYSE - Delayed Quote USD

Baxter International Inc. (BAX)

Compare

29.42

-0.17

(-0.57%)

At close: January 10 at 4:00:02 PM EST

29.40

-0.02

(-0.07%)

After hours: January 10 at 6:06:32 PM EST

Should We Be Cautious About Baxter International Inc.'s (NYSE:BAX) ROE Of 1.6%?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Simply Wall St. 13 days ago

BAX
-0.57%
Baxter International Inc. (BAX): Among the Biggest Dividend Cuts and Suspensions of 2024

We recently compiled a list of the 10 Biggest Dividend Cuts and Suspensions of 2024. In this article, we are going to take a look at where Baxter International Inc. (NYSE:BAX) stands against the other stocks. Dividends hold great appeal for investors—they appreciate receiving them and strongly dislike reductions. Despite this, numerous major companies have reduced […]

Insider Monkey 20 days ago

BAX
-0.57%
Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference

DEERFIELD, Ill., December 18, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. José (Joe) E. Almeida, Baxter's chair, president and chief executive officer, is scheduled to present at 10:30 a.m. Pacific Time.

Business Wire 25 days ago

BAX
-0.57%
Baxter Stock May Gain Following Five New Injectable Product Launches

BAX launches five new injectible products in the United States, thus further strengthening its U.S Pharmaceuticals business segment.

Zacks 30 days ago

BAX
-0.57%
GMED
Baxter Announces Continued Growth of Pharmaceuticals Portfolio With Five Injectable Product Launches in the U.S.

DEERFIELD, Ill., December 11, 2024--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product launches in the U.S., joining the previous five launches announced in April of this year and marking a total of 10 U.S. injectable product launches in 2024.

Business Wire last month

BAX
-0.57%
Is the Options Market Predicting a Spike in Baxter International (BAX) Stock?

Investors need to pay close attention to Baxter International (BAX) stock based on the movements in the options market lately.

Zacks last month

BAX
-0.57%
Should You Hold Baxter International (BAX) for the Long Term?

Broyhill Asset Management, an investment advisor, released a third-quarter 2024, investor letter. A copy of the letter can be downloaded here. Broyhill Partners appreciated 6% net of all fees and expenses in the third quarter. The top contributors in the quarter were Philip Morris, Fiserv, Avantor, and Baxter. There was only one material detractor: Dollar […]

Insider Monkey last month

BAX
-0.57%
New Strong Sell Stocks for November 29th

BALY, BAX and CENTA have been added to the Zacks Rank #5 (Strong Sell) List on November 29, 2024.

Zacks last month

BAX
-0.57%
New Strong Sell Stocks for November 21st

BATRA, BAX and BRKR have been added to the Zacks Rank #5 (Strong Sell) List on November 21, 2024.

Zacks last month

BAX
-0.57%
Baxter to Present at 7th Annual Evercore HealthCONx Conference

DEERFIELD, Ill., November 19, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 7th Annual Evercore HealthCONx Conference on Thursday, December 5, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 9:10 a.m. Eastern Time.

Business Wire last month

BAX
-0.57%
Baxter to Present at Jefferies London Healthcare Conference

DEERFIELD, Ill., November 13, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 11:00 a.m. Greenwich Mean Time.

Business Wire last month

BAX
-0.57%
Decoding Baxter International Inc (BAX): A Strategic SWOT Insight

Insightful Analysis of Baxter International's Financial Health and Strategic Position

GuruFocus.com last month

BAX
-0.57%
Baxter to Present at Stifel 2024 Healthcare Conference

DEERFIELD, Ill., November 12, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Stifel 2024 Healthcare Conference on Monday, November 18, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 8:35 a.m. Eastern Time.

Business Wire last month

BAX
-0.57%
Baxter Declares Quarterly Dividend

DEERFIELD, Ill., November 11, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on Jan. 2, 2025, to stockholders of record as of Nov. 29, 2024. The indicated annual dividend rate is $0.68 per share of common stock.

Business Wire 2 months ago

BAX
-0.57%
Q3 2024 Baxter International Inc Earnings Call

Q3 2024 Baxter International Inc Earnings Call

Thomson Reuters StreetEvents 2 months ago

BAX
-0.57%
Baxter International Inc (BAX) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...

Baxter International Inc (BAX) reports a 4% sales increase and surpasses EPS guidance, while navigating operational impacts from Hurricane Helene.

GuruFocus.com 2 months ago

BAX
-0.57%
BAX Stock Falls Despite Q3 Earnings & Sales Beat, Margins Decline

Baxter reports better-than-expected third-quarter results. However, the company's gross and operating margins contract. Shares fall.

Zacks 2 months ago

BAX
-0.57%
GMED
Baxter (BAX) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks 2 months ago

BAX
-0.57%
Baxter International (BAX) Beats Q3 Earnings Estimates

Baxter (BAX) delivered earnings and revenue surprises of 2.56% and 29.72%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

BAX
-0.57%
Baxter International Q3 Adjusted Earnings Fall, Net Sales Rise; 2024 Guidance Lowered -- Shares Down Pre-Bell

Baxter International Q3 Adjusted Earnings Fall, Net Sales Rise; 2024 Guidance Lowered -- Shares Down Pre-Bell

PREMIUM
MT Newswires 2 months ago

BAX
-0.57%

Performance Overview

Return	BAX	S&P 500
YTD	+2.76%	-1.35%
1-Year	-25.56%	+22.51%
3-Year	-63.74%	+24.59%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Baxter International Inc. (BAX)

Should We Be Cautious About Baxter International Inc.'s (NYSE:BAX) ROE Of 1.6%?

Baxter International Inc. (BAX): Among the Biggest Dividend Cuts and Suspensions of 2024

Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference

Baxter Stock May Gain Following Five New Injectable Product Launches

Baxter Announces Continued Growth of Pharmaceuticals Portfolio With Five Injectable Product Launches in the U.S.

Is the Options Market Predicting a Spike in Baxter International (BAX) Stock?

Should You Hold Baxter International (BAX) for the Long Term?

New Strong Sell Stocks for November 29th

New Strong Sell Stocks for November 21st

Baxter to Present at 7th Annual Evercore HealthCONx Conference

Baxter to Present at Jefferies London Healthcare Conference

Decoding Baxter International Inc (BAX): A Strategic SWOT Insight

Baxter to Present at Stifel 2024 Healthcare Conference

Baxter Declares Quarterly Dividend

Q3 2024 Baxter International Inc Earnings Call

Baxter International Inc (BAX) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...

BAX Stock Falls Despite Q3 Earnings & Sales Beat, Margins Decline

Baxter (BAX) Reports Q3 Earnings: What Key Metrics Have to Say

Baxter International (BAX) Beats Q3 Earnings Estimates

Baxter International Q3 Adjusted Earnings Fall, Net Sales Rise; 2024 Guidance Lowered -- Shares Down Pre-Bell

Performance Overview